In the PPAR signaling pathway, the upregulation of PPARγ and its target gene FABP4, along with the significant downregulation of lipid synthesis enzyme SCD, reveals that EA-2 may remodel tumor cell lipid metabolism by activating the PPARγ pathway [55,56]. The gene discussed is FABP4; the disease is neoplasm.